Delivering critical regulatory submissions on time and with impeccable accuracy defines my professional approach. At BioGenix Pharma, I spearheaded the comprehensive Investigational New Drug (IND) application for a novel oncology biologic, navigating a condensed 6-month submission timeline. My meticulous coordination of cross-functional teams and synthesis of complex preclinical and clinical data resulted in agency approval without major deficiencies, significantly advancing the program toward Phase I trials. This successful outcome underscores my ability to transform intricate scientific information into compliant and persuasive documentation for regulatory bodies, directly contributing to accelerated drug development pathways.
My expertise spans the full spectrum of medical writing deliverables. I have authored and finalized eight complex Clinical Study Reports (CSRs) for Phase III trials, integrating statistical analyses and clinical narratives using Veeva Vault for rigorous version control, directly supporting subsequent NDA filings. Furthermore, I developed 15+ abstracts and 5 peer-reviewed manuscripts for high-impact journals, achieving over 300 citations across my publication portfolio by collaborating closely with principal investigators. I also crafted comprehensive medical education materials for two major drug launches, including slide decks and training modules, ensuring accurate and compliant messaging.
Veridian Health Sciences' groundbreaking work in gene therapy for neurodegenerative diseases, particularly your recent breakthroughs in Project Cerebrum, deeply resonates with my professional aspirations. My strength lies in translating complex scientific data into clear, compliant regulatory documents, a skill vital for communicating the intricate mechanisms and trial results of novel therapies. My experience in synthesizing extensive literature reviews and developing compelling scientific narratives would be instrumental in articulating Veridian's innovations, ensuring both regulatory success and broad scientific understanding within this rapidly evolving field.
My six years of experience at BioGenix Pharma, focused on meticulously crafting compliant and impactful medical documents, makes me confident in my ability to immediately contribute to Veridian's cutting-edge pipeline. I am adept at navigating stringent regulatory landscapes and simplifying intricate scientific concepts for diverse audiences. I am eager to discuss how my proven track record in accelerating regulatory processes and enhancing scientific dissemination can support Veridian Health Sciences' mission. Please feel free to contact me to schedule a conversation at your earliest convenience.
Best regards,
Fatima Hassan